Premium
Regenerative ophthalmology: Technologic and pharmacologic approaches to restoring sight via retinal prosthesis
Author(s) -
Iezzi R
Publication year - 2016
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.292
Subject(s) - retinitis pigmentosa , medicine , retinal implant , retina , ophthalmology , retinal prosthesis , retinal , regenerative medicine , neuroscience , optometry , stem cell , psychology , biology , genetics
Retinal prosthesis technology can restore rudimentary form vision in patients with retinitis pigmentosa (RP) who have lost all eyesight. This continually advancing field within regenerative ophthalmology represents the merger of micro‐electromechanical systems technology with neurosensory retina. This man‐machine interface is reliant upon the long‐term health of a neurosensory retina undergoing progressive pathophysiologic changes. Pharmacologic approaches that address the pathophysiologic consequences of RP will likely play an important role for all regenerative treatment strategies.